548 Avsnitt

  1. A Heart Attack that Led to a Rare Disease Diagnosis

    Publicerades: 2025-01-30
  2. Targeting Rare Liver Diseases with Gene Editing Therapies

    Publicerades: 2025-01-23
  3. Using AI to De-Risk Rare Disease Drug Development

    Publicerades: 2025-01-16
  4. Addressing a Growing Demand for Plasma-Derived Therapies

    Publicerades: 2025-01-09
  5. Empowering Patients with Data to Drive Drug Development

    Publicerades: 2025-01-02
  6. How Advocates Are Advancing a Treatment for an Ultra-Rare Disease

    Publicerades: 2024-12-26
  7. Engineering B Cells to Produce Therapeutic Proteins

    Publicerades: 2024-12-19
  8. A Pipeline Win as BridgeBio Learns to Balance Theory with Practice

    Publicerades: 2024-12-12
  9. Considering What It Will Take for Payers to Embrace Advances in Sequencing

    Publicerades: 2024-12-05
  10. Finding Strength

    Publicerades: 2024-11-27
  11. A Non-Profit Works to Advance a DMD Gene Therapy

    Publicerades: 2024-11-21
  12. Accepting What We Can’t Understand

    Publicerades: 2024-11-14
  13. A Gene Therapy Company Born from a Father’s Efforts to Save his Daughter

    Publicerades: 2024-11-07
  14. Lowering Barriers to Clinical Trial Participation with Do-It-Yourself Blood Sample Collection

    Publicerades: 2024-10-31
  15. Scaling N-of-1 Therapies to Viability

    Publicerades: 2024-10-24
  16. Building Gene Therapies that Address Gain and Loss of Function Simultaneously

    Publicerades: 2024-10-17
  17. How One Woman Climbed from Patient to Advocate

    Publicerades: 2024-10-10
  18. Shortening the Diagnostic Odyssey

    Publicerades: 2024-10-03
  19. Making Exomes More Revealing

    Publicerades: 2024-09-26
  20. How One Patient Organization Catalyzed Drug Development

    Publicerades: 2024-09-19

2 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site